"On that point an A$55M market cap is absurdly low for a company in this position. At a P: E of 30 this would imply a profit of just US$1.7M which seems like a low ball even for this FY given the ramp up in sales NOW. It is fair to say healthy investor skepticism has created a massive opportunity for new shareholders here'
That is possible on an underlying annual EBITDA basis maybe not so much on a statutory basis , however maybe they should be pushing as much R&D and marketing costs as possible that can be amortized short term so that EBITDA over a 3 year period is not positive ?
That is how I do it anyway (on a small scale) as prefer to spend money on patents and product development and market penetration (topline ) to reduce profits and increase the underlying value and sustainability of the company (building a mote ) rather than pay extra tax which is dead money . In the case of Alexium I would think Alexium has an extra string to its bow as plenty of tax losses they can bring forward to defer tax !
Guessing poster PhantomGWW can relate to that
AJX Price at posting:
8.6¢ Sentiment: None Disclosure: Held
